The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 34.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,380 shares of the medical device company’s stock after buying an additional 1,134 shares during the quarter. SG Americas Securities LLC’s holdings in Cooper Companies were worth $403,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Ashton Thomas Securities LLC purchased a new position in Cooper Companies in the third quarter worth $25,000. Covestor Ltd increased its holdings in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. lifted its stake in shares of Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. Friedenthal Financial acquired a new stake in shares of Cooper Companies in the third quarter valued at about $50,000. Finally, Cromwell Holdings LLC purchased a new stake in Cooper Companies during the third quarter worth about $52,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $96.55 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $19.27 billion, a PE ratio of 49.51, a P/E/G ratio of 2.48 and a beta of 0.99. The firm has a 50 day simple moving average of $95.79 and a 200-day simple moving average of $99.71. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm posted $0.87 EPS. Cooper Companies’s revenue was up 9.8% on a year-over-year basis. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

COO has been the subject of a number of research analyst reports. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.